HCQ and covid pathology – Swiss Policy Research

In recent weeks, several more prospective and retrospective studies have confirmed the effectiveness of malaria drug HCQ against covid-19, both in primary care and in hospitals, and both in the general population and in nursing homes. The studies typically found risk reductions between 30% and 50% (e.g. reduced hospitalizations, disease duration or mortality). At this…
— Weiterlesen swprs.org/2020/08/26/hcq-and-pathology/